Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...
Most generic drugs are made overseas — which can cause problems for U.S. consumers. But this tariff might not be a cost-effective solution for Americans.
Despite ongoing advancements in genomics, artificial intelligence, and precision medicine, clinical trial success rates have ...
The Hatch-Waxman Act of 1984, which gave rise to the modern generic drug market, was one of the most significant cost-reducing policy innovations of the last 40 years. In 2021 alone, the use of ...
A generic attention deficit hyperactive disorder (ADHD) drug manufactured by Mallinckrodt has been found by the US Food and Drug Administration (FDA) to not be sufficiently equivalent to its reference ...
US regulatory officials say they have identified not one but two supposed generic copies of the attention deficit hyperactive disorder (ADHD) treatment drug Concerta that have failed to demonstrate ...
Risk assessments of drug-related problems for cardiac surgery patients can be conducted by implementing a framework for patient safety. Objectives: Patients undergoing cardiac surgery are considered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results